Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19

Condition:   Covid19 Interventions:   Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector);   Biological: Placebo Sponsors:   NPO Petrovax;   CanSino Biologics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials